Objective To confirmed reliability and feasibility of intranasal nerve growth factor （NGF） bypassing the blood-brain barrier and its potential neuroprotective effects on acute cerebral ischemia. Methods （1） To assay NGF concentrations in different brain regions after middle cerebral artery occlusion （MCAO）.Rats were randomly divided into intranasal （IN） NGF

intravenous （IV） NGF

and untreated group （n= 4）. The concentra-tions of NGF of different brain regions in the three groups after MCAO were measured by ELISA. （2） To observe neuro-protective action of NGF on focal cerebral ischemic damage. Rats were randomly assigned to 4 groups: IN vehicle

IN NGF

IV vehicle

IV NGF （n= 8）. Treatment was initiated 30 minutes after onset of MCAO and given again 24 hours later. Three neurologic behavioral tests were performed 24 and 48 hours following onset of MCAO. Corrected infarct volumes were determined 48 hours after onset of MCAO. Results The olfactory bulb in IN NGF group obtained the highest concentration （3252 pg/g） of NGF among all regions

followed by the hippocampus. The NGF concentrations in the olfactory bulb and hippocampus in IN NGF group were markedly higher than that in IV NGF and control groups. The infarct volume in IN NGF group was markedly reduced by 38.8% compared with IN vehicle group. IN NGF group vestibulum function markedly improved compared with IN vehicle group at 24 and 48 hours after onset of MCAO （P 24 h = 0.02 and P 48 h = 0.04

respectively）. Conclusion Intranasal NGF could pass through the blood-brain barrier

reach the central nervous system

reduce infarct volume

and improve neurologic function in rats following MCAO. Intranasal delivery of NGF may be a promising treat-ment for stroke.